Imperva Inc. (NYSE:IMPV) insider Amichai Shulman sold 3,085 shares of the business’s stock in a transaction that occurred on Monday, October 17th. The stock was sold at an average price of $48.57, for a total value of $149,838.45. Following the completion of the sale, the insider now owns 91,062 shares of the company’s stock, valued at $4,422,881.34. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Amichai Shulman also recently made the following trade(s):

  • On Monday, October 3rd, Amichai Shulman sold 938 shares of Imperva stock. The stock was sold at an average price of $53.27, for a total value of $49,967.26.
  • On Friday, September 23rd, Amichai Shulman sold 937 shares of Imperva stock. The stock was sold at an average price of $51.00, for a total value of $47,787.00.
  • On Thursday, September 15th, Amichai Shulman sold 3,085 shares of Imperva stock. The stock was sold at an average price of $44.30, for a total value of $136,665.50.
  • On Monday, August 15th, Amichai Shulman sold 3,085 shares of Imperva stock. The stock was sold at an average price of $46.87, for a total value of $144,593.95.
  • On Wednesday, July 27th, Amichai Shulman sold 3,085 shares of Imperva stock. The stock was sold at an average price of $46.28, for a total value of $142,773.80.

Shares of Imperva Inc. (NYSE:IMPV) opened at 46.65 on Wednesday. The stock’s 50 day moving average price is $48.32 and its 200 day moving average price is $44.74. The company’s market cap is $1.52 billion. Imperva Inc. has a one year low of $31.11 and a one year high of $77.99.

Imperva (NYSE:IMPV) last released its quarterly earnings results on Thursday, August 4th. The company reported ($0.23) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by $0.19. The firm had revenue of $57.87 million for the quarter, compared to analyst estimates of $66.06 million. Imperva had a negative return on equity of 25.68% and a negative net margin of 23.75%. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same period in the previous year, the business posted ($0.08) earnings per share. Equities analysts predict that Imperva Inc. will post ($0.80) earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Imperva (NYSE:IMPV)

A number of research analysts have recently commented on IMPV shares. Macquarie started coverage on Imperva in a report on Friday, July 8th. They set a “neutral” rating and a $46.00 price target for the company. Imperial Capital reiterated an “outperform” rating and set a $50.00 price target (down from $55.00) on shares of Imperva in a report on Monday, August 8th. Nomura reiterated a “buy” rating and set a $55.00 price target (down from $60.00) on shares of Imperva in a report on Friday, July 15th. JPMorgan Chase & Co. reiterated a “hold” rating and set a $46.00 price target on shares of Imperva in a report on Friday, August 5th. Finally, Needham & Company LLC upgraded Imperva from a “hold” rating to a “buy” rating and set a $64.00 price objective on the stock in a research report on Friday, August 5th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $52.33.

Hedge funds have recently added to or reduced their stakes in the company. Robeco Institutional Asset Management B.V. boosted its stake in Imperva by 20.0% in the second quarter. Robeco Institutional Asset Management B.V. now owns 30,000 shares of the company’s stock valued at $1,290,000 after buying an additional 5,000 shares during the last quarter. Parametrica Management Ltd purchased a new stake in Imperva during the second quarter valued at $396,000. Eagle Asset Management Inc. boosted its stake in Imperva by 3.1% in the second quarter. Eagle Asset Management Inc. now owns 1,338,055 shares of the company’s stock valued at $57,549,000 after buying an additional 40,709 shares during the last quarter. Fisher Asset Management LLC purchased a new stake in Imperva during the second quarter valued at $5,942,000. Finally, Jacobs Levy Equity Management Inc. boosted its stake in Imperva by 198.0% in the first quarter. Jacobs Levy Equity Management Inc. now owns 54,560 shares of the company’s stock valued at $2,755,000 after buying an additional 36,250 shares during the last quarter. 93.27% of the stock is owned by institutional investors and hedge funds.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.

5 Day Chart for NYSE:IMPV

Receive News & Stock Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related stocks with our FREE daily email newsletter.